“OUTCOME OF FRONTLINE TREATMENT WITH ‘GENERIC’ IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY”, Mediterr J Hematol Infect Dis, vol. 9, no. 1, p. e2017062, Oct. 2017, doi: 10.4084/mjhid.2017.062.